ProfileGDS4516 / 202685_s_at
TitleColorectal cancer: laser microdissected tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 1 stage: 2a stage: 2b stage: 3a stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM537341 GSM537345 GSM537355 GSM537366 GSM537370 GSM537380 GSM537392 GSM537415 GSM537417 GSM537422 GSM537423 GSM537427 GSM537430 GSM537336 GSM537337 GSM537348 GSM537349 GSM537356 GSM537361 GSM537374 GSM537377 GSM537378 GSM537379 GSM537383 GSM537388 GSM537395 GSM537400 GSM537404 GSM537409 GSM537418 GSM537425 GSM537333 GSM537342 GSM537347 GSM537350 GSM537362 GSM537363 GSM537368 GSM537376 GSM537381 GSM537386 GSM537398 GSM537402 GSM537405 GSM537371 GSM537421 GSM537424 GSM537432 GSM537331 GSM537332 GSM537334 GSM537338 GSM537353 GSM537357 GSM537358 GSM537375 GSM537389 GSM537390 GSM537393 GSM537399 GSM537407 GSM537408 GSM537428 GSM537354 GSM537410 GSM537413 GSM537396 GSM537397 GSM537330 GSM537369 GSM537373 GSM537401 GSM537343 GSM537367 GSM537382 GSM537385 GSM537391 GSM537419 GSM537420 GSM537429 GSM537431 GSM537387 GSM537414 GSM537433 GSM537335 GSM537339 GSM537340 GSM537344 GSM537346 GSM537351 GSM537352 GSM537359 GSM537360 GSM537364 GSM537365 GSM537372 GSM537384 GSM537394 GSM537403 GSM537406 GSM537411 GSM537412 GSM537416 GSM537426 57% 58% 56% 57% 48% 52% 53% 53% 61% 59% 56% 48% 59% 54% 54% 54% 57% 56% 58% 60% 63% 51% 56% 55% 55% 49% 58% 54% 48% 50% 54% 59% 56% 57% 54% 54% 60% 58% 60% 56% 60% 56% 57% 57% 56% 57% 55% 55% 61% 50% 58% 55% 52% 54% 54% 56% 51% 55% 51% 63% 62% 56% 54% 53% 57% 51% 52% 55% 54% 49% 55% 58% 55% 56% 52% 59% 55% 57% 57% 52% 63% 53% 56% 56% 50% 51% 58% 57% 51% 62% 56% 55% 53% 58% 57% 61% 54% 56% 59% 58% 60% 53% 54% 59% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM537341patient 115, cancer, LCM [OPG study]5.9092357
GSM537345patient 119, cancer, LCM [OPG study]5.9419158
GSM537355patient 138, cancer, LCM [OPG study]5.8447556
GSM537366patient 154, cancer, LCM [OPG study]5.8479257
GSM537370patient 022, cancer, LCM [OPG study]5.2876448
GSM537380patient 037, cancer, LCM [OPG study]5.5484652
GSM537392patient 077, cancer, LCM [OPG study]5.6034253
GSM537415patient 032, cancer, LCM [OPG study]5.582853
GSM537417patient 042, cancer, LCM [OPG study]6.173661
GSM537422patient 059, cancer, LCM [OPG study]5.9835559
GSM537423patient 064, cancer, LCM [OPG study]5.8264356
GSM537427patient 084, cancer, LCM [OPG study]5.2672748
GSM537430patient 090, cancer, LCM [OPG study]6.029959
GSM537336patient 107, cancer, LCM [OPG study]5.6684554
GSM537337patient 108, cancer, LCM [OPG study]5.6384554
GSM537348patient 124, cancer, LCM [OPG study]5.6468154
GSM537349patient 125, cancer, LCM [OPG study]5.8388357
GSM537356patient 139, cancer, LCM [OPG study]5.8197856
GSM537361patient 147, cancer, LCM [OPG study]5.9419558
GSM537374patient 026, cancer, LCM [OPG study]6.1043560
GSM537377patient 033, cancer, LCM [OPG study]6.3287363
GSM537378patient 034, cancer, LCM [OPG study]5.4692651
GSM537379patient 036, cancer, LCM [OPG study]5.7875956
GSM537383patient 046, cancer, LCM [OPG study]5.6994355
GSM537388patient 063, cancer, LCM [OPG study]5.7793355
GSM537395patient 082, cancer, LCM [OPG study]5.3476949
GSM537400patient 099, cancer, LCM [OPG study]5.9782258
GSM537404patient 129, cancer, LCM [OPG study]5.6541654
GSM537409patient 141, cancer, LCM [OPG study]5.2862748
GSM537418patient 044, cancer, LCM [OPG study]5.4045950
GSM537425patient 070, cancer, LCM [OPG study]5.6478854
GSM537333patient 102, cancer, LCM [OPG study]6.016459
GSM537342patient 116, cancer, LCM [OPG study]5.8370456
GSM537347patient 123, cancer, LCM [OPG study]5.8985357
GSM537350patient 127, cancer, LCM [OPG study]5.7372154
GSM537362patient 148, cancer, LCM [OPG study]5.6522554
GSM537363patient 150, cancer, LCM [OPG study]6.0293260
GSM537368patient 156, cancer, LCM [OPG study]5.9310958
GSM537376patient 031, cancer, LCM [OPG study]6.1168160
GSM537381patient 038, cancer, LCM [OPG study]5.8087156
GSM537386patient 057, cancer, LCM [OPG study]6.0480560
GSM537398patient 094, cancer, LCM [OPG study]5.8032356
GSM537402patient 109, cancer, LCM [OPG study]5.8888357
GSM537405patient 130, cancer, LCM [OPG study]5.8962357
GSM537371patient 023, cancer, LCM [OPG study]5.7933756
GSM537421patient 055, cancer, LCM [OPG study]5.8477357
GSM537424patient 065, cancer, LCM [OPG study]5.7465455
GSM537432patient 097, cancer, LCM [OPG study]5.7794655
GSM537331patient 100, cancer, LCM [OPG study]6.1414761
GSM537332patient 101, cancer, LCM [OPG study]5.4225950
GSM537334patient 103, cancer, LCM [OPG study]5.9094958
GSM537338patient 110, cancer, LCM [OPG study]5.7854755
GSM537353patient 135, cancer, LCM [OPG study]5.5232452
GSM537357patient 142, cancer, LCM [OPG study]5.6816454
GSM537358patient 143, cancer, LCM [OPG study]5.6649954
GSM537375patient 030, cancer, LCM [OPG study]5.7947256
GSM537389patient 068, cancer, LCM [OPG study]5.4148851
GSM537390patient 072, cancer, LCM [OPG study]5.6759955
GSM537393patient 078, cancer, LCM [OPG study]5.4089751
GSM537399patient 095, cancer, LCM [OPG study]6.2828263
GSM537407patient 133, cancer, LCM [OPG study]6.1871362
GSM537408patient 140, cancer, LCM [OPG study]5.8053356
GSM537428patient 086, cancer, LCM [OPG study]5.7326554
GSM537354patient 136, cancer, LCM [OPG study]5.6068353
GSM537410patient 146, cancer, LCM [OPG study]5.8550657
GSM537413patient 027, cancer, LCM [OPG study]5.4638251
GSM537396patient 083, cancer, LCM [OPG study]5.570552
GSM537397patient 088, cancer, LCM [OPG study]5.7216255
GSM537330patient 006, cancer, LCM [OPG study]5.7118454
GSM537369patient 015, cancer, LCM [OPG study]5.3249
GSM537373patient 025, cancer, LCM [OPG study]5.7159255
GSM537401patient 106, cancer, LCM [OPG study]5.9418658
GSM537343patient 117, cancer, LCM [OPG study]5.6689955
GSM537367patient 155, cancer, LCM [OPG study]5.7700256
GSM537382patient 041, cancer, LCM [OPG study]5.5756852
GSM537385patient 053, cancer, LCM [OPG study]6.0034359
GSM537391patient 073, cancer, LCM [OPG study]5.7437155
GSM537419patient 045, cancer, LCM [OPG study]5.8871857
GSM537420patient 052, cancer, LCM [OPG study]5.8750857
GSM537429patient 089, cancer, LCM [OPG study]5.5246252
GSM537431patient 096, cancer, LCM [OPG study]6.2945763
GSM537387patient 061, cancer, LCM [OPG study]5.6142453
GSM537414patient 028, cancer, LCM [OPG study]5.7452256
GSM537433patient 098, cancer, LCM [OPG study]5.7899956
GSM537335patient 104, cancer, LCM [OPG study]5.4045950
GSM537339patient 111, cancer, LCM [OPG study]5.4494851
GSM537340patient 113, cancer, LCM [OPG study]5.9025758
GSM537344patient 118, cancer, LCM [OPG study]5.8256357
GSM537346patient 011, cancer, LCM [OPG study]5.4529651
GSM537351patient 128, cancer, LCM [OPG study]6.2565962
GSM537352patient 134, cancer, LCM [OPG study]5.7823256
GSM537359patient 144, cancer, LCM [OPG study]5.7834455
GSM537360patient 145, cancer, LCM [OPG study]5.5739453
GSM537364patient 152, cancer, LCM [OPG study]5.8964458
GSM537365patient 153, cancer, LCM [OPG study]5.8450957
GSM537372patient 024, cancer, LCM [OPG study]6.1796761
GSM537384patient 048, cancer, LCM [OPG study]5.7074454
GSM537394patient 081, cancer, LCM [OPG study]5.7821156
GSM537403patient 121, cancer, LCM [OPG study]5.9945259
GSM537406patient 131, cancer, LCM [OPG study]5.9593858
GSM537411patient 149, cancer, LCM [OPG study]6.1061560
GSM537412patient 019, cancer, LCM [OPG study]5.6475253
GSM537416patient 035, cancer, LCM [OPG study]5.6325754
GSM537426patient 079, cancer, LCM [OPG study]6.0148959